Login / Signup

Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster.

Alan W GemmillJessica Lee OlivaJennifer EricksenCharlene HoltChristopher J HoltJeannette Milgrom
Published in: BMC psychiatry (2022)
Findings paralleled the magnitude of symptom reductions seen in randomised trials of the postnatal MumMoodBooster program, suggesting that Mum2BMoodBooster is an effective treatment for depressed pregnant women. Effective internet therapies are likely to become increasingly important as the COVID-19 pandemic continues to make face-to-face access to health care problematic during 'lockdowns'.
Keyphrases
  • pregnant women
  • healthcare
  • clinical trial
  • depressive symptoms
  • randomized controlled trial
  • open label
  • study protocol
  • health information
  • combination therapy
  • social media